https://www.thetarheeljournal.com/article/906172481-exit-factor-expands-raleigh-presence-to-serve-the-greater-raleigh-durham-market The Tar Heel Journal en PressRelease 2026-04-20T12:00:00+00:00 Exit Factor Expands Raleigh Presence to Serve the Greater Raleigh-Durham Market https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834733-exit-factor-logo-2000x2000.jpeg https://www.thetarheeljournal.com/article/906901844-surety-one-inc-deploys-customs-bonds-com-client-portal-for-every-cbp-activity-code-powered-by-janus-assurance-re-a-i The Tar Heel Journal en PressRelease 2026-04-20T08:18:07+00:00 Surety One, Inc. Deploys Customs-Bonds.com Client Portal for Every CBP Activity Code, Powered by Janus Assurance Re A.I. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836071-customs-bonds-com-1200x700.jpeg https://www.thetarheeljournal.com/article/906936859-take-5-oil-change-expands-footprint-in-daytona-beach-with-new-location The Tar Heel Journal en PressRelease 2026-04-20T12:01:00+00:00 Take 5 Oil Change Expands Footprint in Daytona Beach with New Location https://ml.globenewswire.com/media/9c7e0991-d918-49d5-937d-779e1b723738/medium/new-take-5-oil-change-in-daytona-beach.png https://www.thetarheeljournal.com/article/906937079-atsena-therapeutics-receives-data-monitoring-committee-recommendation-to-proceed-with-pivotal-part-c-cohort-of-phase-1-2-3-lighthouse-trial-evaluating The Tar Heel Journal en PressRelease 2026-04-20T12:00:00+00:00 Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg https://www.thetarheeljournal.com/article/906937184-askbio-s-viralgen-to-supply-commercial-scale-drug-product-for-regenerate-pd-investigational-gene-therapy-phase-ii-trial-for-parkinson-s-disease The Tar Heel Journal en PressRelease 2026-04-20T12:00:00+00:00 AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease https://ml.globenewswire.com/media/MTk3Y2I1OTYtYWYwYy00MDFmLWFlNTctYTVhZjUyODU0NTNlLTEyODY3MTItMjAyNi0wNC0yMC1lbg==/tiny/Asklepios-BioPharmaceutical-In.png https://www.thetarheeljournal.com/article/906932010-lumexa-imaging-appoints-kyle-lynch-as-chief-growth-officer The Tar Heel Journal en PressRelease 2026-04-20T11:00:00+00:00 Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer https://ml.globenewswire.com/media/NjRkZGYxOTQtZWU0Yi00NDY3LTk4MGQtYzVlNTYwZGMzYWJkLTEzMTc0MTMtMjAyNi0wNC0yMC1lbg==/tiny/Lumexa-Imaging-Inc-.png https://www.thetarheeljournal.com/article/882363964-dr-michael-c-threatt-presented-sha-s-2026-state-of-the-housing-authority-releases-better-together-performance-report The Tar Heel Journal en PressRelease 2026-04-19T16:00:00+00:00 Dr. Michael C. Threatt Presented SHA's 2026 State of the Housing Authority & Releases Better Together Performance Report https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832602-last-message-from-the-sha-s-ceo-1350x1688.png